WASHINGTON — Raj Panjabi has made a career out of taking on some of public health’s toughest challenges, from malaria to Ebola to Covid-19 to mpox.
Panjabi’s next act will be leading a team at Flagship Pioneering. That team, which is focused on preventative medicine, has been around for three years.
The group could grow under four main categories, Panjabi said: preparing for infectious disease threats, delaying the onset of disease, biosecurity, and pursuing bolder early treatments for diseases with public health consequences like obesity, cancer, and neurodegenerative illnesses.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect